---
figid: PMC7435717__molecules-25-03442-g005
figtitle: Effect of Icariin, Purmorphamine, U0126, and PD98059 on osteogenic signaling
  pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7435717
filename: molecules-25-03442-g005.jpg
figlink: pmc/articles/PMC7435717/figure/molecules-25-03442-f005/
number: F5
caption: The effect of Icariin, Purmorphamine, U0126, and PD98059 on osteogenic signaling
  pathways. Icariin activates PI3K/Akt, promoting downstream RUNX2 expression and
  osteogenic lineage commitment. Purmorphamine stimulates Smoothened (Smo), activating
  the Hedgehog (Hh) signaling pathway, resulting in the upregulation of its downstream
  target gene GLI1, as well as the Wnt/β-catenin signaling pathway, leading to bone
  formation and the promotion of osteogenic lineage commitment. Icariin also regulates
  osteogenic commitment via the Wnt/β-catenin pathway. U0126 and PD98059 act as MAPK/ERK
  mitogen activated kinase (MAPK) inhibitors, resulting in inhibition of osteogenic
  lineage commitment.
papertitle: 3D Bioprinted Osteogenic Tissue Models for In Vitro Drug Screening.
reftext: Erick Breathwaite, et al. Molecules. 2020 Aug;25(15):3442.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9198821
figid_alias: PMC7435717__F5
figtype: Figure
redirect_from: /figures/PMC7435717__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7435717__molecules-25-03442-g005.html
  '@type': Dataset
  description: The effect of Icariin, Purmorphamine, U0126, and PD98059 on osteogenic
    signaling pathways. Icariin activates PI3K/Akt, promoting downstream RUNX2 expression
    and osteogenic lineage commitment. Purmorphamine stimulates Smoothened (Smo),
    activating the Hedgehog (Hh) signaling pathway, resulting in the upregulation
    of its downstream target gene GLI1, as well as the Wnt/β-catenin signaling pathway,
    leading to bone formation and the promotion of osteogenic lineage commitment.
    Icariin also regulates osteogenic commitment via the Wnt/β-catenin pathway. U0126
    and PD98059 act as MAPK/ERK mitogen activated kinase (MAPK) inhibitors, resulting
    in inhibition of osteogenic lineage commitment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - ptc
  - smo
  - sm
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - Akt
  - Dsor1
  - Mtk
  - arm
  - Taz
  - Dis3
  - rk
  - daw
  - Ablp
  - KRAS
  - HRAS
  - NRAS
  - DHH
  - IHH
  - SHH
  - PTCH1
  - SMO
  - SMOX
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CTNNB1
  - TAFAZZIN
  - WWTR1
  - RUNX2
  - BGLAP
  - ALPP
  - ATHS
  - SLPI
  - CCL27
  - ATRNL1
  - PDLIM3
  - NAT10
  - ASRGL1
  - PD98059
  - U0126
  - PTCH
  - Purmorphamine
  - Icariin
  - ALP
---
